Igene Biotechnology Inc (IGNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2004 | 03-2004 | 12-2003 | 09-2003 | 06-2003 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,430 | -920 | -2,190 | -1,520 | -890 |
| Depreciation Amortization | 10 | 5 | 80 | 70 | 60 |
| Other Working Capital | 290 | 250 | 1,080 | 560 | 400 |
| Other Operating Activity | 2,090 | 765 | 860 | 670 | 400 |
| Operating Cash Flow | $-40 | $100 | $-170 | $-220 | $-30 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | 0 | 0 | 7 | 3 |
| Other Investing Activity | 0 | 0 | -10 | 0 | 0 |
| Investing Cash Flow | $0 | $0 | $-10 | $7 | $3 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 10 | 10 | -250 | -250 | -100 |
| Financing Cash Flow | $10 | $10 | $-250 | $-250 | $-100 |
| Beginning Cash Position | 60 | 60 | 490 | 490 | 490 |
| End Cash Position | 30 | 180 | 60 | 20 | 360 |
| Net Cash Flow | $-20 | $120 | $-430 | $-470 | $-130 |
| Free Cash Flow | |||||
| Operating Cash Flow | -40 | 100 | -170 | -220 | -30 |
| Free Cash Flow | -40 | 100 | -170 | -220 | -30 |